ADVERTISEMENT
COVID-19, SARS-CoV-2, coronavirus, pandemic, vaccine, vaccine trials, combination, mix and match, immunity, antibodies, T cells, Pfizer, Moderna, AstraZeneca, clinical trials
COVID-19 Vaccine Combos Aim to Boost Immunity
Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.
COVID-19 Vaccine Combos Aim to Boost Immunity
COVID-19 Vaccine Combos Aim to Boost Immunity

Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.

Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.

virus, cell & molecular biology, disease & medicine

COVID-19, SARS-CoV-2, pandemic, research, reverse genetics, toolkit, antibodies, RNA
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Asher Jones | Mar 3, 2021 | 6 min read
Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.
Infographic: How SARS-CoV-2 Immune Responses May Differ by Sex
Catherine Offord | Mar 1, 2021 | 2 min read
Males and females show differences in gene expression, cell activation, and antibody production in response to some viral infections, but whether these influence COVID-19 outcomes is still unclear.
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Anthony King | Nov 11, 2020 | 5 min read
Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 
SARS-CoV-2 Disables Key Components of Human Cells’ Defense System
Catherine Offord | Oct 22, 2020 | 4 min read
Researchers detail how viral proteins interact with host RNA to disrupt the cell’s ability to fight back against infection.
Blood Pressure Meds Point the Way to Possible COVID-19 Treatment
Ashley Yeager | Apr 2, 2020 | 7 min read
There is little evidence that antihypertensive drugs worsen COVID-19, and scientists are instead exploring the idea that such medications—or their downstream effects—may actually alleviate symptoms.
Cracking Down on Cancer: A Profile of Owen Witte
Diana Kwon | Apr 1, 2020 | 9 min read
Through his studies on cancer-causing viruses, the University of California, Los Angeles, professor has helped develop lifesaving treatments.
Novel DNA-Sensing Pathway Found in Human Cells, Absent in Mice
Catherine Offord | Jan 24, 2020 | 4 min read
This previously unknown mechanism for spotting foreign genetic material in the cytoplasm launches antiviral defenses even when the well-known immune mediator STING is absent.
The Scientist Infographics: Editor’s Picks of 2019
Jef Akst | Dec 18, 2019 | 3 min read
This year’s most beautiful illustrations covered topics including the molecular underpinnings of Parkinson’s disease and strategies for tracking marine organisms around the world’s oceans.
mouse foot 28 days post chikungunya infection
Image of the Day: Viral Residue
Nicoletta Lanese | Aug 30, 2019 | 1 min read
Genetic material from the chikungunya virus remains in mouse cells after infection and may be linked to later joint pain.
ADVERTISEMENT